Signs and symptoms indicative of community-acquired pneumonia in infants under six months
Related Experiment Video
Updated: Aug 16, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Maria de Fátima Bazhuni Pombo March1, Clemax Couto Sant'Anna
1Martagão Gesteira Pediatric Institute, Dept. of Pediatrics, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Insights
Clinical signs and symptoms do not reliably distinguish bacterial from viral pneumonia in young children. The findings support Brazil's national program for early pneumonia diagnosis, regardless of the cause.
Area of Science:
- Pediatrics
- Infectious Diseases
- Respiratory Medicine
Background:
- Pneumonia is a leading cause of mortality in children under five.
- Differentiating between bacterial and viral pneumonia is crucial for appropriate treatment.
- The Brazilian National Control Program for Acute Respiratory Infections (ARI) aims for early pneumonia diagnosis.
Purpose of the Study:
- To evaluate clinical signs and symptoms for predicting bacterial versus viral pneumonia in infants.
- To assess the efficacy of these indicators in the context of the Brazilian ARI program.
Main Methods:
- An observational prospective study involving 76 infants (birth to 6 months) with pneumonia.
- Patients were categorized into bacterial (n=47) or viral (n=29) pneumonia based on radiological findings.
- Frequencies, sensitivities, and specificities of various clinical signs and symptoms were analyzed.
Main Results:
- No specific clinical signs or symptoms reliably differentiated bacterial from viral pneumonia.
- Fever, hypoactivity, and prostration showed varying sensitivities and specificities in both groups.
- Respiratory findings like cough, respiratory rate, auscultation, and chest indrawing also lacked distinct predictive value for etiology.
Conclusions:
- Clinical presentation alone is insufficient to distinguish bacterial from viral pneumonia in infants.
- The findings support the Brazilian ARI program's approach to early pneumonia diagnosis, irrespective of the causative agent.
- This reinforces the program's adequacy in managing pediatric pneumonia effectively.
Objective:
Evaluation of the clinical signs and symptoms predicting bacterial and viral pneumonia, in accordance with the Brazilian National Control Program for Acute Respiratory (ARI).
Methods:
Observational prospective study. Seventy-six children from birth to six months of age who had pneumonia were studied in the emergency room. The patients were subdivided into two groups, based on radiological findings (gold-standard): 47 had bacterial pneumonia, and 29 had viral pneumonia. The frequencies, sensitivities, and specificities of the signs and symptoms were evaluated.
Results:
The sensibilities and sensitivities of general findings in bacterial pneumonia were, respectively: fever 53.2%/40.0%; hypoactivity 68.4%/55.6% and prostration detected by the doctor 72.7%/55.0%. The same findings in viral pneumonias showed, respectively: 37.9%/40.0%, 66.7%/55.6% and 66.7%/55.6%. The sensibilities and sensitivities of respiratory findings in bacterial pneumonia were, respectively: coughing 66.0/38.1%, Respiratory rate = 50 ripm 76.6%/38.1%, altered respiratory auscultation 91.3%/10.5%, and chest indrawing 46.7%/80.0%. The same findings in viral pneumonias were, respectively: 69.0%/38.1%, 86.2%/38.1%, 85.7%/10.5% and 44.8%/80.0%.
Conclusion:
Analysis of signs and symptoms in each group did not distinguish bacterial from viral pneumonia. Our findings reinforce the adequacy of the ARI program in Brazil, which gives an early diagnosis of pneumonia, independent of its etiology.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Respiratory Syncytial Virus Disease